A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cell

• Publication date

  1991-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(91)90010-VPMID 1648448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The fate of CD4-8- T cell receptor-alpha beta+ thymocytes.

  1991cited by this paper
• Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation.

  1991cited by this paper
• A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells.

  1990cited by this paper
• PCR protocols — A guide to methods and applications

  1990cited by this paper
• Receptor tyrosine kinases: genetic evidence for their role in Drosophila and mouse development.

  1990cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• Cellular and developmental properties of fetal hematopoietic stem cells.

  1990influential reference
• Steel locus defines new multipotent growth factor.

  1990cited by this paper
• The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.

  1990cited by this paper
• Molecular and cellular events of T cell development.

  1989cited by this paper
• Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell.

  1989cited by this paper
• PCR-based cDNA library construction: general cDNA libraries at the level of a few cells.

  1989influential reference
• Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.

  1989influential reference
• Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family.

  1989cited by this paper
• Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.

  1989cited by this paper
• Isolation in a single step of a highly enriched murine hematopoietic stem cell population with competitive long-term repopulating ability.

  1989cited by this paper
• Purification and characterization of mouse hematopoietic stem cells.

  1988cited by this paper
• The immunoglobulin superfamily--domains for cell surface recognition.

  1988cited by this paper
• Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells.

  1988cited by this paper
• The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus

  1988cited by this paper
• The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

  1988cited by this paper
• Fetal liver blast cell colonies: a source of erythroid progenitors.

  1988cited by this paper
• The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.

  1988cited by this paper
• Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer.

  1988cited by this paper
• The human hematopoietic colony-stimulating factors.

  1987cited by this paper
• Growth and differentiation in the hemopoietic system.

  1987cited by this paper
• Isolation of murine pluripotent hemopoietic stem cells in the Go phase.

  1987cited by this paper
• Growth And Differentiation In The Hematopoietic System

  1987cited by this paper
• Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

  1986cited by this paper
• Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors

  1986cited by this paper
• An attempt to produce “pre‐T” cell hybridomas and to identify their antigens

  1986cited by this paper
• Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.

  1986cited by this paper
• Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

  1985cited by this paper
• Enrichment of hematopoietic precursor cells and cloning of multipotential B-lymphocyte precursors.

  1985cited by this paper
• Compilation of published signal sequences.

  1984cited by this paper
• A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

  1984cited by this paper
• A comprehensive set of sequence analysis programs for the VAX

  1984cited by this paper
• Characterization of two populations of CFU‐S fractionated from mouse fetal liver by fluorescence‐activated cell sorting

  1984cited by this paper
• A simple and very efficient method for generating cDNA libraries.

  1983cited by this paper
• Patterns of amino acids near signal-sequence cleavage sites.

  1983cited by this paper
• Patterns of Amino Acids near Signal‐Sequence Cleavage Sites

  1983cited by this paper
• Renewal and commitment to differentiation of hemopoietic stem cells (an interpretive review).

  1983cited by this paper
• Renewal and commitment to differentiation of hemopoietic stem cells (an interpretive review)

  1983cited by this paper
• Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

  1983cited by this paper
• Hematopoietic stem cells with high proliferative potential. Assay of their concentration in marrow by the frequency and duration of cure of W/Wv mice.

  1982cited by this paper
• IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

  1980cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• Hereditary anemias of the mouse: a review for geneticists.

  1979cited by this paper
• Preparative and analytical purification of DNA from agarose.

  1979cited by this paper
• "Panning" for lymphocytes: a method for cell selection.

  1978cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper

• FLT3: A narrative review

  2025cites this paper
• FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma

  2025cites this paper
• Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data

  2025cites this paper
• Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture

  2025cites this paper
• Rational design of next-generation FLT3 inhibitors in acute myeloid leukemia: From laboratory to clinics.

  2025cites this paper
• Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

  2024cites this paper
• Advances in Prostate Cancer Biomarkers and Probes

  2024cites this paper
• Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges.

  2024cites this paper
• FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice

  2024cites this paper
• Cytotoxicity of Doxorubicin-Curcumin Nanoparticles Conjugated with Two Different Peptides (CKR and EVQ) against FLT3 Protein in Leukemic Stem Cells

  2024cites this paper
• Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas.

  2024cites this paper
• Prevalence of FLT3 gene mutation and its expression in Brazilian pediatric B-ALL patients: clinical implications

  2024cites this paper
• Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.

  2024cites this paper
• GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2

  2023cites this paper
• Prognostic relevance of NPM1, CEBPA, and FLT3 mutations in cytogenetically normal adult AML patients.

  2023cites this paper
• FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis

  2023cites this paper
• Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

  2023cites this paper
• Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes

  2023cites this paper
• A review on inflammation and angiogenesis as key mechanisms involved in the pathogenesis of bovine cystic ovarian disease.

  2022cites this paper
• Doxorubicin-Loaded Polymeric Micelles Conjugated with CKR- and EVQ-FLT3 Peptides for Cytotoxicity in Leukemic Stem Cells

  2022cites this paper
• Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

  2022cites this paper
• Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD

  2022cites this paper
• “FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors

  2022cites this paper
• Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field

  2022cites this paper
• Identification of Differentially Expressed Genes and Key Pathways Associated with PTPN11 Mutation in Acute Myeloid Leukemia

  2022cites this paper
• High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer

  2022cites this paper
• A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL

  2022cites this paper
• FLT3-targeted treatment for acute myeloid leukemia

  2022cites this paper
• The effect of co-treatments of chemotherapeutic drugs and curcumin on cytotoxicity and FLT3 protein expression in leukemic stem cells

  2021cites this paper
• The RARγ Oncogene: An Achilles Heel for Some Cancers

  2021cites this paper
• Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells

  2021cites this paper
• FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

  2021cites this paper
• Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells

  2021cites this paper
• The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy

  2021cites this paper
• The Role of Lymphangiogenesis in Coronary Atherosclerosis

  2021cites this paper
• Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia

  2021cites this paper
• Regulatory Dendritic Cells Induced by Bendamustine Are Associated With Enhanced Flt3 Expression and Alloreactive T-Cell Death

  2021cites this paper
• Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

  2021cites this paper
• The genomics of acute myeloid leukemia in children

  2020cites this paper
• Identification and Development of 1,4-Diaryl-1,2,3-triazolo-Based Ureas as Novel FLT3 Inhibitors.

  2020cites this paper
• Successful treatment with avapritinib in patient with mucosal metastatic melanoma

  2020cites this paper
• Machine Learning of Hematopoietic Stem Cell Divisions from Paired Daughter Cell Expression Profiles Reveals Effects of Aging on Self-Renewal.

  2020cites this paper
• FLT3 ligand in acute myeloid leukemia: a simple test with deep implications

  2020cites this paper
• Mécanismes de chronicisation de la douleur post-opératoire.

  2020cites this paper
• Crosstalk Between the Hepatic and Hematopoietic Systems During Embryonic Development

  2020cites this paper
• Identification of novel point mutations in c-kit gene from Leukemia cases: a study from Lucknow, Uttar Pradesh, India

  2020cites this paper
• Deciphering the molecular mechanism of FLT3 resistance mutations.

  2020cites this paper
• Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

  2020cites this paper
• Dendritic cells responses to biomaterials

  2020cites this paper
• Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3

  2019cites this paper
• Neuroprotective effect of FMS-like tyrosine kinase-3 silence on cerebral ischemia/reperfusion injury in a SH-SY5Y cell line.

  2019cites this paper
• Risk assessment of FLT3 and PAX5 variants in B-acute lymphoblastic leukemia: a case–control study in a Pakistani cohort

  2019cites this paper
• Conformational modifications induced by internal tandem duplications on the FLT3 kinase and juxtamembrane domains.

  2019cites this paper
• From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia

  2019cites this paper
• Activation and Inactivation of the FLT3 Kinase: Pathway Intermediates and the Free Energy of Transition.

  2019cites this paper
• FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications.

  2019cites this paper
• Quizartinib (AC220): a promising option for acute myeloid leukemia

  2019cites this paper
• Quizartinib (AC220): a promising option for acute myeloid leukemia

  2019cites this paper
• Early mortality in acute promyelocytic leukemia: Potential predictors

  2018cites this paper
• The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients

  2018cites this paper
• The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules

  2018cites this paper
• Conventional Dendritic Cells Impair Recovery after Myocardial Infarction

  2018cites this paper
• Direct role of FLT3 in regulation of early lymphoid progenitors

  2018cites this paper
• Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis

  2018cites this paper
• Remembering Ihor Lemischka—The scientist's scientist

  2018cites this paper
• Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases.

  2018cites this paper
• Comparison of Biodosimetry Biomarkers for Radiation Dose and Injury Assessment After Mixed-Field (Neutron and Gamma) and Pure Gamma Radiation in the Mouse Total-Body Irradiation Model

  2018cites this paper
• Vascular endothelial growth factor signaling in development and disease

  2018cites this paper
• Analysis of the presence of FLT 3 gene mutation and association with prognostic factors in adult and pediatric acute leukemia patients

  2017cites this paper
• The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis

  2017cites this paper
• Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment

  2017cites this paper
• Flt 3 ligand-eGFP-reporter expression characterizes functionally distinct subpopulations of CD 150 + long-term repopulating murine hematopoietic stem cells

  2017cites this paper
• FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics

  2017cites this paper
• 6 Regulation of Tyrosine Kinase Signaling by Cbl in Hematopoietic Stem Cells

  2017cites this paper
• FLT 3 inhibitors : clinical potential in acute myeloid leukemia

  2017cites this paper
• The ontogeny of inflammatory macrophages and monocyte-derived dendritic cells

  2017cites this paper
• Caracterització de les alteracions moleculars de FLT3 en pacients pediàtrics afectes de leucèmia aguda. Correlació amb l’activitat i expressió dels transportadors de fàrmacs derivats de nucleòsids

  2017cites this paper
• Charakterisierung von FLT3 assoziierten Signaltransduktionsproteinen und TET2 als epigenetischer Regulator in der akuten myeloischen Leukämie

  2017cites this paper
• Identification of New FLT3 Inhibitors That Potently Inhibit AML Cell Lines via an Azo Click-It/Staple-It Approach.

  2017cites this paper
• Analysis of the presence of FLT3 gene mutation and association with prognostic factors in adult and pediatric acute leukemia patients

  2017cites this paper
• Development of platelets during steady state and inflammation

  2017cites this paper
• Flt3 ligand‐eGFP‐reporter expression characterizes functionally distinct subpopulations of CD150+ long‐term repopulating murine hematopoietic stem cells

  2017cites this paper
• FLT3 inhibitors: clinical potential in acute myeloid leukemia

  2017cites this paper
• Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia

  2017cites this paper
• Inhibiting Downstream Signaling Pathway of FIT3 inn Acute Myeloid Leukemia

  2017cites this paper
• Molecular Regulation of Sprouting Angiogenesis.

  2017cites this paper
• The origin of Juvenile Myelomonocytic Leukemia : Insights from developmental hematopoiesis

  2017cites this paper
• Microenvironnement médullaire et résistance des LAM FLT3-ITD aux inhibiteurs de tyrosine kinase : Rôle pivot du récepteur TAM AXL

  2017cites this paper
• Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma.

  2016cites this paper
• FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines.

  2016cites this paper
• FMS-Like Tyrosine Kinase-3

  2016cites this paper
• RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells

  2016cites this paper
• The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells*

  2016cites this paper
• Tyrosine Kinase Signaling Pathways in Normal and Cancer Cells

  2016cites this paper
• Impaired signaling through the Fms‐like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis

  2016cites this paper
• [The clinical and prognostic significance of acute myeloid leukemia with FLT3-ITD].

  2016cites this paper
• On the origin of B cells. Elucidating the Role of Tyrosine Kinase Receptors in B Cell Development.

  2016cites this paper
• Gr upSM Azacytidine Enhances Efficacy of Tyrosine Kinase Inhibitors in Aml Cells

  2016cites this paper
• THE CRISPR/CAS9-CREATED MDM2 T309G ENHANCES VITREOUS-INDUCED EXPRESSION OF MDM2 AND PROLIFERATION AND SURVIVAL OF CELLS

  2016cites this paper
• SIMULTANEOUS INHIBITION OF DRIVER AND EFFECTOR KINASES PROMOTES POTENT GROWTH ARREST OF AML CELLS IN VITRO AND IN VIVO

  2016cites this paper